"According to the latest report published by Data Bridge Market Research, the Microbiology Testing Market The global microbiology testing market was valued at USD 5.47 billion in 2024 and is expected to reach USD 10.99 billion by 2032 During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 9.10% Competitive analysis carried out in...

"According to the latest report published by Data Bridge Market Research, the Targeted Cancer Drugs Market The global targeted cancer drugs market size was valued at USD 75.05 billion in 2025and is expected to reach USD 91.44 billion by 2033, at a CAGR of 2.50% during the forecast period Winning Targeted Cancer Drugs Market research report is a persuaded...

According to the latest report published by Data Bridge Market Research, the Tumor Ablation Market  CAGR Value The global tumor ablation market size was valued at USD 1.94 billion in 2024 and is expected to reach USD 5.47 billion by 2032, at a CAGR of 13.8% during the forecast period The large scale Tumor Ablation Market report evaluates CAGR value fluctuation during the forecast...

" According to the latest report published by Data Bridge Market Research, the Cancer Biological Therapy Market The global cancer biological therapy market size was valued at USD 133.32 billion in 2025 and is expected to reach USD 246.76 billion by 2033, at a CAGR of 8.00% during the forecast period. The supreme Cancer Biological Therapy Market research report has been built by...

" According to the latest report published by Data Bridge Market Research, the Cancer Monoclonal Antibodies Market The global cancer monoclonal antibodies market size was valued at USD 53.33 billion in 2023 and is expected to reach USD 133.45 billion by 2031, at a CAGR of 14.00% during the forecast period. The world-class Cancer Monoclonal Antibodies Market report analyses some of the...

According to a new report from Intel Market Research, the global Cordyceps Militaris market was valued at USD 1.45 billion in 2025 and is projected to grow from USD 1.62 billion in 2026 to USD 3.28 billion by 2034, exhibiting a robust CAGR of 9.7% during the forecast period (2026–2034). This growth is propelled by increasing consumer awareness of adaptogenic herbs, rising demand for...

According to a newly published market research report by 24LifeSciences, global endometrial cancer treatment market was valued at USD 21,380 million in 2024 and is projected to reach USD 28,790 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025–2031. Endometrial cancer, classified under gynecologic malignancies, originates in the...

According to a newly published market research report by 24LifeSciences, the global prostate cancer diagnosis and therapy market was valued at USD 17.2 billion in 2024 and is projected to reach USD 23.5 billion by 2032, growing at a compound annual growth rate (CAGR) of 4.8% during the forecast period 20252032. Prostate cancer, the second most common cancer in men globally, requires a...

According to a newly published market research report by 24LifeSciences, global prostate cancer treatment drugs market was valued at USD 14.03 billion in 2024 and is projected to reach USD 18.74 billion by 2031, growing at a compound annual growth rate (CAGR) of 4.3% during the forecast period 2025-2031. Prostate cancer treatment drugs represent a critical segment in oncology therapeutics,...

According to a newly published market research report by 24LifeSciences, theglobal thymus cancer market was valued at USD 149 million in 2025 and is projected to reach USD 213 million by 2031, growing at a compound annual growth rate (CAGR) of 5.3% during the forecast period 2025–2031. Thymus cancer, clinically referred to as thymoma or thymic carcinoma, is a rare malignancy...